nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—melanoma	0.788	1	CbGaD
Nizatidine—Vasculitis—Vemurafenib—melanoma	0.00499	0.0286	CcSEcCtD
Nizatidine—Tooth disorder—Temozolomide—melanoma	0.00384	0.022	CcSEcCtD
Nizatidine—Eosinophilia—Vemurafenib—melanoma	0.00303	0.0173	CcSEcCtD
Nizatidine—Liver injury—Temozolomide—melanoma	0.00296	0.017	CcSEcCtD
Nizatidine—Ranitidine—ABCB1—melanoma	0.00287	1	CrCbGaD
Nizatidine—Hepatic enzyme increased—Temozolomide—melanoma	0.00263	0.0151	CcSEcCtD
Nizatidine—Gynaecomastia—Carmustine—melanoma	0.00231	0.0132	CcSEcCtD
Nizatidine—Back pain—Vemurafenib—melanoma	0.00206	0.0118	CcSEcCtD
Nizatidine—Nasal congestion—Temozolomide—melanoma	0.00198	0.0114	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Temozolomide—melanoma	0.00192	0.011	CcSEcCtD
Nizatidine—Cough—Vemurafenib—melanoma	0.00186	0.0107	CcSEcCtD
Nizatidine—Bronchospasm—Bleomycin—melanoma	0.00182	0.0104	CcSEcCtD
Nizatidine—Myalgia—Vemurafenib—melanoma	0.00181	0.0104	CcSEcCtD
Nizatidine—Anaphylactic shock—Vemurafenib—melanoma	0.00174	0.00996	CcSEcCtD
Nizatidine—Infection—Vemurafenib—melanoma	0.00173	0.0099	CcSEcCtD
Nizatidine—Pneumonia—Bleomycin—melanoma	0.00166	0.00952	CcSEcCtD
Nizatidine—Hepatocellular injury—Docetaxel—melanoma	0.00166	0.00949	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00158	0.00908	CcSEcCtD
Nizatidine—Pneumonia—Dactinomycin—melanoma	0.00155	0.00888	CcSEcCtD
Nizatidine—Decreased appetite—Vemurafenib—melanoma	0.00151	0.00866	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Vemurafenib—melanoma	0.0015	0.0086	CcSEcCtD
Nizatidine—Constipation—Vemurafenib—melanoma	0.00149	0.00852	CcSEcCtD
Nizatidine—Pneumonia—Carmustine—melanoma	0.00145	0.00831	CcSEcCtD
Nizatidine—Erectile dysfunction—Temozolomide—melanoma	0.00144	0.00825	CcSEcCtD
Nizatidine—Pneumonia—Temozolomide—melanoma	0.0014	0.00803	CcSEcCtD
Nizatidine—Hepatitis—Dactinomycin—melanoma	0.00138	0.00792	CcSEcCtD
Nizatidine—Body temperature increased—Vemurafenib—melanoma	0.00137	0.00788	CcSEcCtD
Nizatidine—Pharyngitis—Dactinomycin—melanoma	0.00137	0.00786	CcSEcCtD
Nizatidine—Sinusitis—Temozolomide—melanoma	0.00131	0.00749	CcSEcCtD
Nizatidine—Hepatitis—Temozolomide—melanoma	0.00125	0.00717	CcSEcCtD
Nizatidine—Asthenia—Vemurafenib—melanoma	0.00125	0.00715	CcSEcCtD
Nizatidine—Pharyngitis—Temozolomide—melanoma	0.00124	0.00711	CcSEcCtD
Nizatidine—Pruritus—Vemurafenib—melanoma	0.00123	0.00705	CcSEcCtD
Nizatidine—Anaemia—Bleomycin—melanoma	0.00119	0.00684	CcSEcCtD
Nizatidine—Diarrhoea—Vemurafenib—melanoma	0.00119	0.00682	CcSEcCtD
Nizatidine—Dizziness—Vemurafenib—melanoma	0.00115	0.00659	CcSEcCtD
Nizatidine—Cough—Bleomycin—melanoma	0.00113	0.00645	CcSEcCtD
Nizatidine—Anaemia—Dactinomycin—melanoma	0.00111	0.00637	CcSEcCtD
Nizatidine—Vomiting—Vemurafenib—melanoma	0.00111	0.00633	CcSEcCtD
Nizatidine—Chest pain—Bleomycin—melanoma	0.0011	0.0063	CcSEcCtD
Nizatidine—Myalgia—Bleomycin—melanoma	0.0011	0.0063	CcSEcCtD
Nizatidine—Rash—Vemurafenib—melanoma	0.0011	0.00628	CcSEcCtD
Nizatidine—Dermatitis—Vemurafenib—melanoma	0.0011	0.00628	CcSEcCtD
Nizatidine—Back pain—Carmustine—melanoma	0.00109	0.00624	CcSEcCtD
Nizatidine—Headache—Vemurafenib—melanoma	0.00109	0.00624	CcSEcCtD
Nizatidine—Nasopharyngitis—Docetaxel—melanoma	0.00107	0.00616	CcSEcCtD
Nizatidine—Confusional state—Bleomycin—melanoma	0.00106	0.00609	CcSEcCtD
Nizatidine—Anaphylactic shock—Bleomycin—melanoma	0.00105	0.00604	CcSEcCtD
Nizatidine—Back pain—Temozolomide—melanoma	0.00105	0.00603	CcSEcCtD
Nizatidine—Infection—Bleomycin—melanoma	0.00105	0.006	CcSEcCtD
Nizatidine—Anaemia—Carmustine—melanoma	0.00104	0.00597	CcSEcCtD
Nizatidine—Nausea—Vemurafenib—melanoma	0.00103	0.00592	CcSEcCtD
Nizatidine—Thrombocytopenia—Bleomycin—melanoma	0.00103	0.00591	CcSEcCtD
Nizatidine—Myalgia—Dactinomycin—melanoma	0.00102	0.00587	CcSEcCtD
Nizatidine—Bronchospasm—Docetaxel—melanoma	0.00102	0.00586	CcSEcCtD
Nizatidine—Anaemia—Temozolomide—melanoma	0.00101	0.00577	CcSEcCtD
Nizatidine—Anorexia—Bleomycin—melanoma	0.001	0.00575	CcSEcCtD
Nizatidine—Convulsion—Carmustine—melanoma	0.000976	0.00559	CcSEcCtD
Nizatidine—Infection—Dactinomycin—melanoma	0.000976	0.00559	CcSEcCtD
Nizatidine—Thrombocytopenia—Dactinomycin—melanoma	0.000962	0.00551	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00096	0.0055	CcSEcCtD
Nizatidine—Myalgia—Carmustine—melanoma	0.000959	0.0055	CcSEcCtD
Nizatidine—Chest pain—Carmustine—melanoma	0.000959	0.0055	CcSEcCtD
Nizatidine—Anxiety—Carmustine—melanoma	0.000956	0.00548	CcSEcCtD
Nizatidine—Cough—Temozolomide—melanoma	0.00095	0.00544	CcSEcCtD
Nizatidine—Convulsion—Temozolomide—melanoma	0.000943	0.00541	CcSEcCtD
Nizatidine—Anorexia—Dactinomycin—melanoma	0.000936	0.00537	CcSEcCtD
Nizatidine—Pneumonia—Docetaxel—melanoma	0.000932	0.00534	CcSEcCtD
Nizatidine—Confusional state—Carmustine—melanoma	0.000927	0.00531	CcSEcCtD
Nizatidine—Myalgia—Temozolomide—melanoma	0.000927	0.00531	CcSEcCtD
Nizatidine—Anxiety—Temozolomide—melanoma	0.000924	0.00529	CcSEcCtD
Nizatidine—Decreased appetite—Bleomycin—melanoma	0.000916	0.00525	CcSEcCtD
Nizatidine—Infection—Carmustine—melanoma	0.000913	0.00523	CcSEcCtD
Nizatidine—Dry mouth—Temozolomide—melanoma	0.000906	0.00519	CcSEcCtD
Nizatidine—Jaundice—Docetaxel—melanoma	0.000903	0.00517	CcSEcCtD
Nizatidine—Pain—Bleomycin—melanoma	0.000901	0.00516	CcSEcCtD
Nizatidine—Thrombocytopenia—Carmustine—melanoma	0.0009	0.00516	CcSEcCtD
Nizatidine—Confusional state—Temozolomide—melanoma	0.000896	0.00513	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000895	0.00513	CcSEcCtD
Nizatidine—Anaphylactic shock—Temozolomide—melanoma	0.000888	0.00509	CcSEcCtD
Nizatidine—Infection—Temozolomide—melanoma	0.000883	0.00506	CcSEcCtD
Nizatidine—Anorexia—Carmustine—melanoma	0.000876	0.00502	CcSEcCtD
Nizatidine—Thrombocytopenia—Temozolomide—melanoma	0.00087	0.00498	CcSEcCtD
Nizatidine—Feeling abnormal—Bleomycin—melanoma	0.000868	0.00497	CcSEcCtD
Nizatidine—Hyperhidrosis—Temozolomide—melanoma	0.000859	0.00492	CcSEcCtD
Nizatidine—Decreased appetite—Dactinomycin—melanoma	0.000854	0.00489	CcSEcCtD
Nizatidine—Anorexia—Temozolomide—melanoma	0.000847	0.00485	CcSEcCtD
Nizatidine—Pain—Dactinomycin—melanoma	0.00084	0.00481	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Carmustine—melanoma	0.000838	0.0048	CcSEcCtD
Nizatidine—Urticaria—Bleomycin—melanoma	0.000837	0.00479	CcSEcCtD
Nizatidine—Rhinitis—Docetaxel—melanoma	0.000834	0.00478	CcSEcCtD
Nizatidine—Body temperature increased—Bleomycin—melanoma	0.000833	0.00477	CcSEcCtD
Nizatidine—Hepatitis—Docetaxel—melanoma	0.000832	0.00477	CcSEcCtD
Nizatidine—Insomnia—Carmustine—melanoma	0.000832	0.00477	CcSEcCtD
Nizatidine—Pharyngitis—Docetaxel—melanoma	0.000825	0.00473	CcSEcCtD
Nizatidine—Somnolence—Carmustine—melanoma	0.000817	0.00468	CcSEcCtD
Nizatidine—Feeling abnormal—Dactinomycin—melanoma	0.000809	0.00464	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000809	0.00464	CcSEcCtD
Nizatidine—Insomnia—Temozolomide—melanoma	0.000804	0.0046	CcSEcCtD
Nizatidine—Gastrointestinal pain—Dactinomycin—melanoma	0.000803	0.0046	CcSEcCtD
Nizatidine—Decreased appetite—Carmustine—melanoma	0.000799	0.00458	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Carmustine—melanoma	0.000794	0.00455	CcSEcCtD
Nizatidine—Somnolence—Temozolomide—melanoma	0.00079	0.00453	CcSEcCtD
Nizatidine—Pain—Carmustine—melanoma	0.000786	0.00451	CcSEcCtD
Nizatidine—Constipation—Carmustine—melanoma	0.000786	0.00451	CcSEcCtD
Nizatidine—Dyspepsia—Temozolomide—melanoma	0.000782	0.00448	CcSEcCtD
Nizatidine—Body temperature increased—Dactinomycin—melanoma	0.000777	0.00445	CcSEcCtD
Nizatidine—Abdominal pain—Dactinomycin—melanoma	0.000777	0.00445	CcSEcCtD
Nizatidine—Decreased appetite—Temozolomide—melanoma	0.000772	0.00443	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Temozolomide—melanoma	0.000767	0.0044	CcSEcCtD
Nizatidine—Pain—Temozolomide—melanoma	0.00076	0.00435	CcSEcCtD
Nizatidine—Constipation—Temozolomide—melanoma	0.00076	0.00435	CcSEcCtD
Nizatidine—Feeling abnormal—Carmustine—melanoma	0.000758	0.00434	CcSEcCtD
Nizatidine—Asthenia—Bleomycin—melanoma	0.000756	0.00433	CcSEcCtD
Nizatidine—Gastrointestinal pain—Carmustine—melanoma	0.000752	0.00431	CcSEcCtD
Nizatidine—Pruritus—Bleomycin—melanoma	0.000745	0.00427	CcSEcCtD
Nizatidine—Feeling abnormal—Temozolomide—melanoma	0.000732	0.0042	CcSEcCtD
Nizatidine—Body temperature increased—Carmustine—melanoma	0.000727	0.00416	CcSEcCtD
Nizatidine—Abdominal pain—Carmustine—melanoma	0.000727	0.00416	CcSEcCtD
Nizatidine—Gastrointestinal pain—Temozolomide—melanoma	0.000726	0.00416	CcSEcCtD
Nizatidine—Urticaria—Temozolomide—melanoma	0.000706	0.00404	CcSEcCtD
Nizatidine—Asthenia—Dactinomycin—melanoma	0.000705	0.00404	CcSEcCtD
Nizatidine—Abdominal pain—Temozolomide—melanoma	0.000702	0.00402	CcSEcCtD
Nizatidine—Body temperature increased—Temozolomide—melanoma	0.000702	0.00402	CcSEcCtD
Nizatidine—Back pain—Docetaxel—melanoma	0.0007	0.00401	CcSEcCtD
Nizatidine—Diarrhoea—Dactinomycin—melanoma	0.000672	0.00385	CcSEcCtD
Nizatidine—Vomiting—Bleomycin—melanoma	0.00067	0.00384	CcSEcCtD
Nizatidine—Anaemia—Docetaxel—melanoma	0.000669	0.00383	CcSEcCtD
Nizatidine—Rash—Bleomycin—melanoma	0.000664	0.00381	CcSEcCtD
Nizatidine—Dermatitis—Bleomycin—melanoma	0.000663	0.0038	CcSEcCtD
Nizatidine—Asthenia—Carmustine—melanoma	0.00066	0.00378	CcSEcCtD
Nizatidine—Asthenia—Temozolomide—melanoma	0.000637	0.00365	CcSEcCtD
Nizatidine—Cough—Docetaxel—melanoma	0.000632	0.00362	CcSEcCtD
Nizatidine—Diarrhoea—Carmustine—melanoma	0.000629	0.0036	CcSEcCtD
Nizatidine—Pruritus—Temozolomide—melanoma	0.000629	0.0036	CcSEcCtD
Nizatidine—Convulsion—Docetaxel—melanoma	0.000627	0.00359	CcSEcCtD
Nizatidine—Nausea—Bleomycin—melanoma	0.000626	0.00359	CcSEcCtD
Nizatidine—Vomiting—Dactinomycin—melanoma	0.000625	0.00358	CcSEcCtD
Nizatidine—Rash—Dactinomycin—melanoma	0.000619	0.00355	CcSEcCtD
Nizatidine—Myalgia—Docetaxel—melanoma	0.000616	0.00353	CcSEcCtD
Nizatidine—Chest pain—Docetaxel—melanoma	0.000616	0.00353	CcSEcCtD
Nizatidine—Dizziness—Carmustine—melanoma	0.000608	0.00348	CcSEcCtD
Nizatidine—Diarrhoea—Temozolomide—melanoma	0.000608	0.00348	CcSEcCtD
Nizatidine—Dry mouth—Docetaxel—melanoma	0.000603	0.00345	CcSEcCtD
Nizatidine—Confusional state—Docetaxel—melanoma	0.000596	0.00341	CcSEcCtD
Nizatidine—Anaphylactic shock—Docetaxel—melanoma	0.000591	0.00339	CcSEcCtD
Nizatidine—Dizziness—Temozolomide—melanoma	0.000588	0.00337	CcSEcCtD
Nizatidine—Infection—Docetaxel—melanoma	0.000587	0.00336	CcSEcCtD
Nizatidine—Vomiting—Carmustine—melanoma	0.000585	0.00335	CcSEcCtD
Nizatidine—Nausea—Dactinomycin—melanoma	0.000583	0.00334	CcSEcCtD
Nizatidine—Rash—Carmustine—melanoma	0.00058	0.00332	CcSEcCtD
Nizatidine—Dermatitis—Carmustine—melanoma	0.000579	0.00332	CcSEcCtD
Nizatidine—Thrombocytopenia—Docetaxel—melanoma	0.000578	0.00332	CcSEcCtD
Nizatidine—Headache—Carmustine—melanoma	0.000576	0.0033	CcSEcCtD
Nizatidine—Vomiting—Temozolomide—melanoma	0.000565	0.00324	CcSEcCtD
Nizatidine—Anorexia—Docetaxel—melanoma	0.000563	0.00323	CcSEcCtD
Nizatidine—Rash—Temozolomide—melanoma	0.00056	0.00321	CcSEcCtD
Nizatidine—Dermatitis—Temozolomide—melanoma	0.00056	0.00321	CcSEcCtD
Nizatidine—Headache—Temozolomide—melanoma	0.000557	0.00319	CcSEcCtD
Nizatidine—Nausea—Carmustine—melanoma	0.000546	0.00313	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000538	0.00308	CcSEcCtD
Nizatidine—Insomnia—Docetaxel—melanoma	0.000534	0.00306	CcSEcCtD
Nizatidine—Nausea—Temozolomide—melanoma	0.000528	0.00302	CcSEcCtD
Nizatidine—Somnolence—Docetaxel—melanoma	0.000525	0.00301	CcSEcCtD
Nizatidine—Dyspepsia—Docetaxel—melanoma	0.00052	0.00298	CcSEcCtD
Nizatidine—Decreased appetite—Docetaxel—melanoma	0.000514	0.00294	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Docetaxel—melanoma	0.00051	0.00292	CcSEcCtD
Nizatidine—Pain—Docetaxel—melanoma	0.000505	0.0029	CcSEcCtD
Nizatidine—Constipation—Docetaxel—melanoma	0.000505	0.0029	CcSEcCtD
Nizatidine—Feeling abnormal—Docetaxel—melanoma	0.000487	0.00279	CcSEcCtD
Nizatidine—Gastrointestinal pain—Docetaxel—melanoma	0.000483	0.00277	CcSEcCtD
Nizatidine—Abdominal pain—Docetaxel—melanoma	0.000467	0.00268	CcSEcCtD
Nizatidine—Body temperature increased—Docetaxel—melanoma	0.000467	0.00268	CcSEcCtD
Nizatidine—Asthenia—Docetaxel—melanoma	0.000424	0.00243	CcSEcCtD
Nizatidine—Pruritus—Docetaxel—melanoma	0.000418	0.0024	CcSEcCtD
Nizatidine—Diarrhoea—Docetaxel—melanoma	0.000404	0.00232	CcSEcCtD
Nizatidine—Dizziness—Docetaxel—melanoma	0.000391	0.00224	CcSEcCtD
Nizatidine—Vomiting—Docetaxel—melanoma	0.000376	0.00215	CcSEcCtD
Nizatidine—Rash—Docetaxel—melanoma	0.000373	0.00213	CcSEcCtD
Nizatidine—Dermatitis—Docetaxel—melanoma	0.000372	0.00213	CcSEcCtD
Nizatidine—Headache—Docetaxel—melanoma	0.00037	0.00212	CcSEcCtD
Nizatidine—Nausea—Docetaxel—melanoma	0.000351	0.00201	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—GNAQ—melanoma	5.69e-05	0.00165	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—CXCL8—melanoma	5.66e-05	0.00164	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—PAX6—melanoma	5.65e-05	0.00164	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GRM1—melanoma	5.61e-05	0.00163	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCR7—melanoma	5.61e-05	0.00163	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—MTAP—melanoma	5.6e-05	0.00163	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.47e-05	0.00159	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SUFU—melanoma	5.47e-05	0.00159	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—HSPA5—melanoma	5.43e-05	0.00158	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—CASP3—melanoma	5.42e-05	0.00157	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—IL2—melanoma	5.41e-05	0.00157	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—BRAF—melanoma	5.4e-05	0.00157	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	5.39e-05	0.00157	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	5.31e-05	0.00154	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AKT3—melanoma	5.25e-05	0.00152	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—BCL2L11—melanoma	5.11e-05	0.00148	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—RHOB—melanoma	5.11e-05	0.00148	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	5.06e-05	0.00147	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—LUM—melanoma	4.99e-05	0.00145	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PHGDH—melanoma	4.99e-05	0.00145	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	4.95e-05	0.00144	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HDAC6—melanoma	4.9e-05	0.00142	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	4.9e-05	0.00142	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—HPSE—melanoma	4.89e-05	0.00142	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—EDN1—melanoma	4.86e-05	0.00141	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	4.85e-05	0.00141	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CUBN—melanoma	4.8e-05	0.00139	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	4.75e-05	0.00138	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CSF2—melanoma	4.75e-05	0.00138	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—PIK3CA—melanoma	4.71e-05	0.00137	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	4.67e-05	0.00135	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CXCR2—melanoma	4.65e-05	0.00135	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—CXCL8—melanoma	4.65e-05	0.00135	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—SDHD—melanoma	4.64e-05	0.00135	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—BSG—melanoma	4.64e-05	0.00135	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CSPG4—melanoma	4.64e-05	0.00135	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ACER3—melanoma	4.64e-05	0.00135	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—VEGFA—melanoma	4.6e-05	0.00134	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	4.58e-05	0.00133	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—RAC2—melanoma	4.57e-05	0.00133	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PRKCA—melanoma	4.55e-05	0.00132	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—MDM2—melanoma	4.53e-05	0.00131	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—WNT5A—melanoma	4.5e-05	0.00131	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—VEGFC—melanoma	4.5e-05	0.00131	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GPAM—melanoma	4.49e-05	0.0013	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	4.49e-05	0.0013	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—EDN1—melanoma	4.41e-05	0.00128	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CSF2—melanoma	4.31e-05	0.00125	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	4.27e-05	0.00124	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—UGT2B10—melanoma	4.24e-05	0.00123	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—RAC1—melanoma	4.22e-05	0.00123	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PRKCA—melanoma	4.13e-05	0.0012	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	4.05e-05	0.00118	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—MAP2K2—melanoma	4.04e-05	0.00117	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	4.04e-05	0.00117	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	4.03e-05	0.00117	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—F2R—melanoma	3.95e-05	0.00115	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TNF—melanoma	3.94e-05	0.00114	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—HS3ST5—melanoma	3.94e-05	0.00114	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—RAC1—melanoma	3.83e-05	0.00111	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EDNRB—melanoma	3.83e-05	0.00111	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PLA2G6—melanoma	3.82e-05	0.00111	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	3.8e-05	0.0011	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	3.75e-05	0.00109	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTK2B—melanoma	3.72e-05	0.00108	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GAB2—melanoma	3.62e-05	0.00105	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GNA11—melanoma	3.62e-05	0.00105	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FLT1—melanoma	3.6e-05	0.00105	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CG—melanoma	3.57e-05	0.00104	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	3.54e-05	0.00103	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	3.48e-05	0.00101	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—VCAN—melanoma	3.43e-05	0.000997	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FOXO4—melanoma	3.4e-05	0.000987	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HDAC2—melanoma	3.4e-05	0.000987	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CXCR4—melanoma	3.4e-05	0.000987	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	3.39e-05	0.000984	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GNAQ—melanoma	3.36e-05	0.000976	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	3.36e-05	0.000975	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.25e-05	0.000943	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	3.24e-05	0.000941	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CG—melanoma	3.24e-05	0.00094	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—MMP1—melanoma	3.21e-05	0.000933	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	3.2e-05	0.000928	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SYK—melanoma	3.16e-05	0.000918	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.14e-05	0.00091	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CD—melanoma	3.14e-05	0.00091	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AKT3—melanoma	3.1e-05	0.000901	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ITGAV—melanoma	3.1e-05	0.000901	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NGFR—melanoma	3.1e-05	0.000901	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—MAPK1—melanoma	3.09e-05	0.000898	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	3.03e-05	0.000881	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.99e-05	0.000868	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PLCB4—melanoma	2.99e-05	0.000867	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.95e-05	0.000856	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP17A1—melanoma	2.9e-05	0.000841	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.88e-05	0.000837	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SOCS1—melanoma	2.87e-05	0.000834	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—MAP2K1—melanoma	2.87e-05	0.000832	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—S100B—melanoma	2.87e-05	0.000832	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.86e-05	0.000829	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CD—melanoma	2.85e-05	0.000827	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	2.82e-05	0.000819	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SLC6A11—melanoma	2.81e-05	0.000816	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIP4K2A—melanoma	2.81e-05	0.000816	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.74e-05	0.000796	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ERBB4—melanoma	2.74e-05	0.000796	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GNA11—melanoma	2.73e-05	0.000794	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CB—melanoma	2.73e-05	0.000793	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—MTAP—melanoma	2.73e-05	0.000793	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.73e-05	0.000793	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CDKN2B—melanoma	2.72e-05	0.000789	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—FASN—melanoma	2.68e-05	0.000777	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.68e-05	0.000777	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—SLC5A5—melanoma	2.63e-05	0.000764	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CD86—melanoma	2.63e-05	0.000763	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CXCL8—melanoma	2.63e-05	0.000762	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EDN1—melanoma	2.61e-05	0.000757	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.6e-05	0.000756	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.58e-05	0.000749	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—IGF1—melanoma	2.57e-05	0.000746	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FGF1—melanoma	2.55e-05	0.00074	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CSF2—melanoma	2.55e-05	0.00074	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GNAQ—melanoma	2.54e-05	0.000738	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CD44—melanoma	2.54e-05	0.000738	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.52e-05	0.000731	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.51e-05	0.00073	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—IL2—melanoma	2.51e-05	0.000729	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.5e-05	0.000726	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—E2F1—melanoma	2.49e-05	0.000724	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.49e-05	0.000723	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—MMP2—melanoma	2.49e-05	0.000722	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—HRAS—melanoma	2.48e-05	0.000721	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CB—melanoma	2.48e-05	0.000721	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PDGFRA—melanoma	2.47e-05	0.000716	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.47e-05	0.000716	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PRKCA—melanoma	2.44e-05	0.000709	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ITGB3—melanoma	2.44e-05	0.000709	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP1B1—melanoma	2.44e-05	0.000708	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—LUM—melanoma	2.44e-05	0.000707	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PHGDH—melanoma	2.44e-05	0.000707	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SPP1—melanoma	2.4e-05	0.000695	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—HPSE—melanoma	2.39e-05	0.000693	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MAP2K2—melanoma	2.39e-05	0.000693	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CXCL8—melanoma	2.38e-05	0.000692	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CUBN—melanoma	2.34e-05	0.000681	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—IL2—melanoma	2.28e-05	0.000662	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TERT—melanoma	2.27e-05	0.000659	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	2.27e-05	0.000659	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—RAC1—melanoma	2.26e-05	0.000657	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SDHD—melanoma	2.26e-05	0.000657	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—BSG—melanoma	2.26e-05	0.000657	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CSPG4—melanoma	2.26e-05	0.000657	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GPAM—melanoma	2.19e-05	0.000637	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HIF1A—melanoma	2.17e-05	0.000631	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.15e-05	0.000625	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	2.15e-05	0.000624	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.09e-05	0.000607	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KDR—melanoma	2.08e-05	0.000603	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CXCL8—melanoma	2.07e-05	0.0006	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.04e-05	0.000593	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.04e-05	0.000593	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ABCB1—melanoma	2.01e-05	0.000583	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FN1—melanoma	2e-05	0.00058	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOTCH1—melanoma	1.96e-05	0.000568	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.95e-05	0.000565	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.93e-05	0.00056	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CD80—melanoma	1.92e-05	0.000556	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CG—melanoma	1.91e-05	0.000555	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KIT—melanoma	1.91e-05	0.000555	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APC—melanoma	1.91e-05	0.000555	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—NRAS—melanoma	1.91e-05	0.000555	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CTNNB1—melanoma	1.91e-05	0.000554	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EGF—melanoma	1.89e-05	0.000549	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PLA2G6—melanoma	1.86e-05	0.000541	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PRKCA—melanoma	1.85e-05	0.000536	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—MAPK3—melanoma	1.83e-05	0.000532	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ERCC2—melanoma	1.83e-05	0.000532	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—BRAF—melanoma	1.8e-05	0.000522	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.77e-05	0.000515	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IGF1—melanoma	1.75e-05	0.000509	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—MAPK1—melanoma	1.74e-05	0.000506	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—EGFR—melanoma	1.74e-05	0.000506	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.72e-05	0.000498	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MAP2K1—melanoma	1.69e-05	0.000492	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CD—melanoma	1.68e-05	0.000488	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—VCAN—melanoma	1.67e-05	0.000486	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CA—melanoma	1.67e-05	0.000484	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—KRAS—melanoma	1.65e-05	0.000478	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FGF2—melanoma	1.61e-05	0.000468	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.52e-05	0.000441	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CA—melanoma	1.51e-05	0.000439	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MDM2—melanoma	1.51e-05	0.000437	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ERBB2—melanoma	1.49e-05	0.000431	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CB—melanoma	1.47e-05	0.000426	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.45e-05	0.000421	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CG—melanoma	1.45e-05	0.00042	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP17A1—melanoma	1.41e-05	0.00041	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CXCL8—melanoma	1.41e-05	0.000409	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—HRAS—melanoma	1.4e-05	0.000406	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PPARG—melanoma	1.4e-05	0.000405	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CDKN1B—melanoma	1.38e-05	0.000399	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—AKT1—melanoma	1.36e-05	0.000395	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CASP3—melanoma	1.35e-05	0.000391	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IL2—melanoma	1.35e-05	0.000391	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—IL6—melanoma	1.34e-05	0.000389	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GNA11—melanoma	1.33e-05	0.000387	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCND1—melanoma	1.31e-05	0.000381	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.31e-05	0.00038	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—FASN—melanoma	1.31e-05	0.000379	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CTNNB1—melanoma	1.3e-05	0.000377	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SLC5A5—melanoma	1.28e-05	0.000373	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MMP9—melanoma	1.27e-05	0.00037	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CD—melanoma	1.27e-05	0.000369	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CDKN1A—melanoma	1.27e-05	0.000369	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTEN—melanoma	1.27e-05	0.000368	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NFKB1—melanoma	1.26e-05	0.000366	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ALB—melanoma	1.26e-05	0.000365	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GNAQ—melanoma	1.24e-05	0.00036	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CD44—melanoma	1.24e-05	0.00036	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AKT1—melanoma	1.24e-05	0.000359	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP1B1—melanoma	1.19e-05	0.000345	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—VEGFA—melanoma	1.14e-05	0.000332	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—STAT3—melanoma	1.13e-05	0.000329	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NRAS—melanoma	1.13e-05	0.000328	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CB—melanoma	1.11e-05	0.000322	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PTGS2—melanoma	1.1e-05	0.000319	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MAPK3—melanoma	1.08e-05	0.000314	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MYC—melanoma	1.05e-05	0.000306	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MAPK1—melanoma	1.03e-05	0.000299	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EGFR—melanoma	1.03e-05	0.000299	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KRAS—melanoma	9.73e-06	0.000282	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PTEN—melanoma	9.58e-06	0.000278	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PRKCA—melanoma	9.01e-06	0.000262	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ERCC2—melanoma	8.94e-06	0.00026	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CA—melanoma	8.94e-06	0.000259	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TP53—melanoma	8.65e-06	0.000251	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HRAS—melanoma	8.27e-06	0.00024	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IL6—melanoma	7.91e-06	0.00023	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AKT1—melanoma	7.3e-06	0.000212	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CG—melanoma	7.06e-06	0.000205	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PPARG—melanoma	6.81e-06	0.000198	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CA—melanoma	6.76e-06	0.000196	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CD—melanoma	6.21e-06	0.00018	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ALB—melanoma	6.13e-06	0.000178	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—AKT1—melanoma	5.52e-06	0.00016	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CB—melanoma	5.41e-06	0.000157	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PTGS2—melanoma	5.36e-06	0.000156	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PTEN—melanoma	4.67e-06	0.000136	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CA—melanoma	3.3e-06	9.57e-05	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—AKT1—melanoma	2.69e-06	7.82e-05	CbGpPWpGaD
